X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (531) 531
Publication (337) 337
Paper (326) 326
Newspaper Article (14) 14
Patent (12) 12
Book / eBook (3) 3
Book Chapter (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (395) 395
particle physics (324) 324
physics (315) 315
high energy physics - experiment (310) 310
physics - high energy physics - experiment (278) 278
high energy physics (256) 256
phenomenology (153) 153
fysik (135) 135
physical sciences (135) 135
physics of elementary particles and fields (124) 124
natural sciences (119) 119
naturvetenskap (119) 119
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (117) 117
nuclear experiment (116) 116
particle physics - experiment (109) 109
hadron-hadron scattering (81) 81
subatomär fysik (55) 55
index medicus (54) 54
subatomic physics (54) 54
physics, particles & fields (52) 52
elementary particles, quantum field theory (49) 49
quantum field theories, string theory (49) 49
astrophysics (47) 47
high energy astrophysical phenomena (46) 46
cern lhc coll (43) 43
detectors (42) 42
science & technology (40) 40
humans (38) 38
cell biology (37) 37
ciências físicas [ciências naturais] (37) 37
experimental results (37) 37
scattering [p p] (35) 35
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (34) 34
collisions (34) 34
classical and quantum gravitation, relativity theory (29) 29
quantum physics (29) 29
física (28) 28
astronomy, astrophysics and cosmology (26) 26
female (25) 25
parton distributions (25) 25
settore med/27 - neurochirurgia (24) 24
8000 gev-cms (23) 23
measurement science and instrumentation (23) 23
nuclear energy (23) 23
astronomy & astrophysics (22) 22
cancer (22) 22
large hadron collider (22) 22
nuclear and high energy physics (22) 22
settore fis/01 - fisica sperimentale (21) 21
nuclear physics, heavy ions, hadrons (20) 20
analysis (19) 19
instrumentation and detectors (19) 19
settore fis/04 - fisica nucleare e subnucleare (19) 19
decay (18) 18
física nuclear (18) 18
lhc (18) 18
model (18) 18
male (17) 17
supersymmetry (17) 17
luminosity (16) 16
mutation (16) 16
oncology (16) 16
article (15) 15
biochemistry & molecular biology (15) 15
engineering (15) 15
physics and astronomy (15) 15
cross sections (14) 14
standard model (14) 14
searching (13) 13
tcga (13) 13
530 physics (12) 12
atlas (12) 12
chemistry (12) 12
jets (12) 12
metallurgy (12) 12
middle aged (12) 12
physics, nuclear (12) 12
aged (11) 11
biology (11) 11
colliding beams [p p] (11) 11
computer science (11) 11
elementary particles (11) 11
hadron colliders (11) 11
hadrons (11) 11
higgs bosons (11) 11
pair production (11) 11
top physics (11) 11
transverse momentum (11) 11
adult (10) 10
bosons (10) 10
expression (10) 10
machine learning (10) 10
matematikk og naturvitenskap: 400::fysikk: 430::kjerne- og elementærpartikkelfysikk: 431 [vdp] (10) 10
mathematics and natural scienses: 400::physics: 430::nuclear and elementary particle physics: 431 [vdp] (10) 10
tumors (10) 10
7000 gev-cms (9) 9
dna methylation (9) 9
genetic aspects (9) 9
human necessities (9) 9
hygiene (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (561) 561
French (4) 4
German (2) 2
Italian (2) 2
Chinese (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 1, pp. 75 - 87
Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1... 
Hematology, Oncology and Palliative Medicine | POLY(ADP-RIBOSE) POLYMERASE | OLAPARIB | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTANT-CELLS | DNA-REPAIR | CANCER | HETEROZYGOSITY | TUMORS | BREAST | GENOMIC LOSS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 23, pp. 2180 - 2190
Journal Article
by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
by Agrawal, Nishant and Akbani, Rehan and Aksoy, B. Arman and Ally, Adrian and Arachchi, Harindra and Asa, Sylvia L and Auman, J. Todd and Balasundaram, Miruna and Balu, Saianand and Baylin, Stephen B and Behera, Madhusmita and Bernard, Brady and Beroukhim, Rameen and Bishop, Justin A and Black, Aaron D and Bodenheimer, Tom and Boice, Lori and Bootwalla, Moiz S and Bowen, Jay and Bowlby, Reanne and Bristow, Christopher A and Brookens, Robin and Brooks, Denise and Bryant, Robert and Buda, Elizabeth and Butterfield, Yaron S.N and Carling, Tobias and Carlsen, Rebecca and Carter, Scott L and Carty, Sally E and Chan, Timothy A and Chen, Amy Y and Cherniack, Andrew D and Cheung, Dorothy and Chin, Lynda and Cho, Juok and Chu, Andy and Chuah, Eric and Cibulskis, Kristian and Ciriello, Giovanni and Clarke, Amanda and Clayman, Gary L and Cope, Leslie and Copland, John A and Covington, Kyle and Danilova, Ludmila and Davidsen, Tanja and Demchok, John A and DiCara, Daniel and Dhalla, Noreen and Dhir, Rajiv and Dookran, Sheliann S and Dresdner, Gideon and Eldridge, Jonathan and Eley, Greg and El-Naggar, Adel K and Eng, Stephanie and Fagin, James A and Fennell, Timothy and Ferris, Robert L and Fisher, Sheila and Frazer, Scott and Frick, Jessica and Gabriel, Stacey B and Ganly, Ian and Gao, Jianjiong and Garraway, Levi A and Gastier-Foster, Julie M and Getz, Gad and Gehlenborg, Nils and Ghossein, Ronald and Gibbs, Richard A and Giordano, Thomas J and Gomez-Hernandez, Karen and Grimsby, Jonna and Gross, Benjamin and Guin, Ranabir and Hadjipanayis, Angela and Harper, Hollie A and Hayes, D. Neil and Heiman, David I and Herman, James G and Hoadley, Katherine A and Hofree, Matan and Holt, Robert A and Hoyle, Alan P and Huang, Mei and Huang, Franklin W and Hutter, Carolyn M and Ideker, Trey and Iype, Lisa and Jacobsen, Anders and Jefferys, Stuart R and Jones, Corbin D and Jones, Steven J.M and Kasaian, Katayoon and Kebebew, Electron and Khuri, Fadlo R and Kim, Jaegil and Kramer, Roger and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Cell, ISSN 0092-8674, 10/2014, Volume 159, Issue 3, pp. 676 - 690
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2521 - 2527
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4095 - 4106
Journal Article
by Thorsson, Vesteinn and Thorsson, Vésteinn and Gibbs, Richard A and Gibbs, David L and Brown, Scott D and Wolf, Gregory and Wolf, Denise and Bortone, Dante S and Ou Yang, Tai-Hsien and Porta-Pardo, Eduard and Gao, Galen F and Gao, Jianjiong and Plaisier, Christopher L and Eddy, James A and Ziv, Elad and Culhane, Aedin C and Paull, Evan O and Sivakumar, I.K. Ashok and Gentles, Andrew J and Malhotra, Raunaq and Farshidfar, Farshad and Colaprico, Antonio and Parker, Joel S and Mose, Lisle E and Vo, Nam Sy and Liu, Wenbin and Liu, Jianfang and Liu, Jia and Liu, Yuexin and Liu, Xiuping and Rader, Janet and Dhankani, Varsha and Reynolds, Sheila and Reynolds, Sheila M and Bowlby, Reanne and Califano, Andrea and Cherniack, Andrew D and Anastassiou, Dimitris and Bedognetti, Davide and Mokrab, Younes and Newman, Aaron M and Rao, Arvind and Chen, Amy and Chen, Chu and Chen, Ken and Krasnitz, Alexander and Hu, Jianhong and Hu, Hai and Malta, Tathiane M and Noushmehr, Houtan and Pedamallu, Chandra Sekhar and Bullman, Susan and Ojesina, Akinyemi I and Lamb, Andrew and Zhou, Wanding and Shen, Hui and Choueiri, Toni K and Weinstein, John N and Guinney, Justin and Saltz, Joel and Holt, Robert and Holt, Robert A and Rabkin, Charles S and Caesar-Johnson, Samantha J and Demchok, John A and Felau, Ina and Kasapi, Melpomeni and Ferguson, Martin L and Hutter, Carolyn M and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Jioajiao and Wang, Min and Wang, Linghua and Wang, Zhining and Wang, Timothy and Wang, Jing and Yang, Ju Dong and Yang, Hannah and Yang, Liming and Yang, Ian and Zenklusen, Jean C and Zhang, Jiashan (Julia) and Zhang, Jiexin and Zhang, Lizhi and Zhang, Wei and Zhang, Hongzheng and Zhang, Hailei and Zhang, Hongxin and Chudamani, Sudha and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Sun, Yichao and Sun, Qiang and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
Immunity, ISSN 1074-7613, 04/2018, Volume 48, Issue 4, pp. 812 - 830.e14
We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across... 
tumor immunology | immunotherapy | cancer genomics | integrative network analysis | immuno-oncology | tumor microenvironment | immune subtypes | immunomodulatory | GENOMIC ANALYSES | INFORMATION | T-CELL-RECEPTOR | REGULATORY NETWORK | CLASSIFICATION | IMMUNOLOGY | SEQUENCING DATA | SOMATIC MUTATIONS | COMPREHENSIVE ANALYSIS | PREDICTION | REVEALS | Transforming Growth Factor beta - immunology | Prognosis | Humans | Middle Aged | Th1-Th2 Balance - physiology | Male | Neoplasms - classification | Wound Healing - immunology | Young Adult | Transforming Growth Factor beta - genetics | Neoplasms - genetics | Neoplasms - immunology | Interferon-gamma - immunology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Interferon-gamma - genetics | Wound Healing - genetics | Genomics - methods | Child | Macrophages - immunology | Cell proliferation | Cluster analysis | Transcription | Copy number | p53 Protein | Lung cancer | Genomics | Aneuploidy | Lymphocytes T | Genomes | Cell interactions | Macrophages | Immunotherapy | DNA methylation | Deoxyribonucleic acid--DNA | Immune system | Medical research | Wound healing | Immunomodulation | MiRNA | Stockholders | Inflammation | T cell receptors | Communications networks | Gene expression | White blood cells | Inventors | Medical prognosis | γ-Interferon | Mutation | Cancer | Tumors
Journal Article